nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A new compound, phomaherbarine A, induces cytolytic reactivation in epstein-barr virus-positive B cell lines
|
Bae, So-Eun |
|
|
227 |
C |
p. |
artikel |
2 |
Characterization of SARS-CoV-2 replication in human H1299/ACE2 cells: A versatile and practical infection model for antiviral research and beyond
|
Salgado-Benvindo, Clarisse |
|
|
227 |
C |
p. |
artikel |
3 |
Cytomegalovirus UL44 protein induces a potent T-cell immune response in mice
|
Mancebo, Francisco J. |
|
|
227 |
C |
p. |
artikel |
4 |
Development of nanoparticle vaccines utilizing designed Fc-binding homo-oligomers and RBD-Fc of SARS-CoV-2
|
Liang, Yucai |
|
|
227 |
C |
p. |
artikel |
5 |
Discovery of baloxavir sodium as a novel anti-CCHFV inhibitor: Biological evaluation of in vitro and in vivo
|
Liu, Kai |
|
|
227 |
C |
p. |
artikel |
6 |
Editorial Board
|
|
|
|
227 |
C |
p. |
artikel |
7 |
Glycyrrhizic acid conjugates with amino acid methyl esters target the main protease, exhibiting antiviral activity against wild-type and nirmatrelvir-resistant SARS-CoV-2 variants
|
Le, Uyen Nguyen Phuong |
|
|
227 |
C |
p. |
artikel |
8 |
JNJ-7184, a respiratory syncytial virus inhibitor targeting the connector domain of the viral polymerase
|
Bonneux, Brecht |
|
|
227 |
C |
p. |
artikel |
9 |
Lectibodies as antivirals
|
Santisteban Celis, Ian Carlosalberto |
|
|
227 |
C |
p. |
artikel |
10 |
Low antiviral resistance in Influenza A and B viruses isolated in Mexico from 2010 to 2023
|
Franco-May, Diana A. |
|
|
227 |
C |
p. |
artikel |
11 |
New technologies in therapeutic antibody development: The next frontier for treating infectious diseases
|
Keating, Sheila M. |
|
|
227 |
C |
p. |
artikel |
12 |
Performance of sofosbuvir and NITD008 in extrahepatic neuronal cells against HEV
|
Jagst, Michelle |
|
|
227 |
C |
p. |
artikel |
13 |
Quantitative HBeAg is a strong predictor of HBeAg loss among patients receiving pegylated interferon
|
Huang, Daniel Q. |
|
|
227 |
C |
p. |
artikel |
14 |
SARS-CoV-2 evolution has increased resistance to monoclonal antibodies and first-generation COVID-19 vaccines: Is there a future therapeutic role for soluble ACE2 receptors for COVID-19?
|
Ameratunga, Rohan |
|
|
227 |
C |
p. |
artikel |
15 |
SRX3177, a CDK4/6-PI3K-BET inhibitor, in combination with an RdRp inhibitor, Molnupiravir, or an entry inhibitor MU-UNMC-2, has potent antiviral activity against the Omicron variant of SARS-CoV-2
|
Pandey, Kabita |
|
|
227 |
C |
p. |
artikel |
16 |
Structural biology of flavivirus NS1 protein and its antibody complexes
|
Alvin Chew, Bing Liang |
|
|
227 |
C |
p. |
artikel |
17 |
6-Thioguanine inhibits severe fever with thrombocytopenia syndrome virus through suppression of EGR1
|
Jiang, Na |
|
|
227 |
C |
p. |
artikel |
18 |
Three in one: An effective and universal vaccine expressing heterologous tandem RBD trimer by rabies virus vector protects mice against SARS-CoV-2
|
Huang, Jingbo |
|
|
227 |
C |
p. |
artikel |